• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs

tetano

Editor, Senior Moderator
PLoS Biol


. 2023 Feb 9;21(2):e3001967.
doi: 10.1371/journal.pbio.3001967. eCollection 2023 Feb.
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs


Lipin Loo[SUP] 1 [/SUP], Matthew A Waller[SUP] 1 [/SUP], Cesar L Moreno[SUP] 1 [/SUP], Alexander J Cole[SUP] 2 [/SUP], Alberto Ospina Stella[SUP] 3 [/SUP], Oltin-Tiberiu Pop[SUP] 4 [/SUP], Ann-Kristin Jochum[SUP] 4 5 [/SUP], Omar Hasan Ali[SUP] 4 6 7 [/SUP], Christopher E Denes[SUP] 1 [/SUP], Zina Hamoudi[SUP] 1 [/SUP], Felicity Chung[SUP] 1 [/SUP], Anupriya Aggarwal[SUP] 3 [/SUP], Jason K K Low[SUP] 8 [/SUP], Karishma Patel[SUP] 8 [/SUP], Rezwan Siddiquee[SUP] 8 [/SUP], Taeyoung Kang[SUP] 9 [/SUP], Suresh Mathivanan[SUP] 9 [/SUP], Joel P Mackay[SUP] 8 [/SUP], Wolfram Jochum[SUP] 5 [/SUP], Lukas Flatz[SUP] 4 10 [/SUP], Daniel Hesselson[SUP] 2 [/SUP], Stuart Turville[SUP] 3 [/SUP], G Gregory Neely[SUP] 1 [/SUP]



Affiliations

Abstract

Although ACE2 is the primary receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, a systematic assessment of host factors that regulate binding to SARS-CoV-2 spike protein has not been described. Here, we use whole-genome CRISPR activation to identify host factors controlling cellular interactions with SARS-CoV-2. Our top hit was a TLR-related cell surface receptor called leucine-rich repeat-containing protein 15 (LRRC15). LRRC15 expression was sufficient to promote SARS-CoV-2 spike binding where they form a cell surface complex. LRRC15 mRNA is expressed in human collagen-producing lung myofibroblasts and LRRC15 protein is induced in severe Coronavirus Disease 2019 (COVID-19) infection where it can be found lining the airways. Mechanistically, LRRC15 does not itself support SARS-CoV-2 infection, but fibroblasts expressing LRRC15 can suppress both pseudotyped and authentic SARS-CoV-2 infection in trans. Moreover, LRRC15 expression in fibroblasts suppresses collagen production and promotes expression of IFIT, OAS, and MX-family antiviral factors. Overall, LRRC15 is a novel SARS-CoV-2 spike-binding receptor that can help control viral load and regulate antiviral and antifibrotic transcriptional programs in the context of COVID-19 infection.
 
Back
Top Bottom